Skip to main content
SpringerLink
Log in

HIV-mediated B-lymphocyte activation and lymphomagenesis

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Non-Hodgkin's1ülymphoma is an AIDS-defining event in a significant percent of U.S. patients infected with the human immunodeficiency virus (HIV). Advances in anti-retroviral treatment and management of opportunistic infection have been accompanied by an increase in the incidence of these lymphomas. In the immunocompromised state of patients late in the course of HIV infection, these lymphomas represent a complication of HIV infection that is associated with an extremely poor prognosis. Currently, there is little understanding of the pathogenesis of HIV-associated lymphomas, which are nearly exclusively of B-cell origin. Experimental data do not support HIV infection in these lymphomas. While some lymphomas show evidence of EBV infection, the majority do not. Polyclonal B-cell hyperactivity during the early phases of HIV infection argues that chronic B-cell stimulation may be the major process predisposing B-cells in the HIV-infected individual to malignant transformation. The mechanism of this stimulation of normal B cells and its relationship to AIDS-associated lymphomas remain poorly understood. In this review, we will summarize current information on HIV-associated B lymphoma and then discuss our views on the association and regulation of HIV-related hyperactivity on the pathogenesis of this lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beral V, Peterman T, Berkelman R,et al.: AIDS-associated non-Hodgkins lymphoma. Lancet 337:805–809, 1991

    PubMed  Google Scholar 

  2. Centers for Disease Control: HIV/AIDS Surveillance Report. U.S. Department of Health and Human Services, 1991

  3. Pluda J, Yarchoan R, Jaffe E: Development of non-Hodgkins lymphoma in a cohort of patients with severe Human Immunodeficiency Virus (HIV) infection on long term antiretroviral therapy. Ann Intern Med 113:276–282, 1990

    PubMed  Google Scholar 

  4. Center for Disease Control:

  5. Pluda J, Yarchoan R, Broder S: HIV-associated non-Hodgkin's lymphoma. Ann Oncol 2:248–249, 1991

    PubMed  Google Scholar 

  6. Gail M, Pluda J, Rabkin C: Projection of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency. J Natl Cancer Inst 83:695–701, 1991

    PubMed  Google Scholar 

  7. Moore R, Kessler H, Richman D,et al.: Non-Hodgkin's lymphomas in patients with advanced HIV infection treated with zidovudine. JAMA 265:2208–2211, 1991

    PubMed  Google Scholar 

  8. Reynolds P, Saunders L, Layefsky M, Lemp G: The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980–1987. Am J Epidemiol 137:19–30, 1993

    PubMed  Google Scholar 

  9. Ziegler J, Beckstead J, Volberding P,et al.: Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565–570, 1984

    PubMed  Google Scholar 

  10. Kaplan L, Abrams D, Feigal E: AIDS-associated non-Hodgkin's lymphomas in San Francisco. JAMA 261:719–724, 1989

    PubMed  Google Scholar 

  11. Subar M, Neri A, Inghirami G,et al.: Frequentc-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667–671, 1988

    PubMed  Google Scholar 

  12. Ammann A, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M: B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 251:1447–1449, 1984

    PubMed  Google Scholar 

  13. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309:453–458, 1983

    PubMed  Google Scholar 

  14. Nicholson JKA, McDougal JS, Spiro TJ, Cross GD, Jones BM, Reinberg EL: Immunoregulatory subsets of the T helper and T suppressor cell population in homosexual men with chronic unexplained lymphadenopathy. J Clin Invest 73:191–201, 1984

    PubMed  Google Scholar 

  15. Fauci AS: Acquired immunodeficiency syndrome: Epidemologic, clinical, immunologic and therapeutic considerations. Ann Intern Med 100:92–106, 1984

    PubMed  Google Scholar 

  16. Roithmann S, Tourani J-M, Andrieu JM: AIDS-associated non-Hodgkin lymphoma. Lancet 338:884–885, 1991

    Google Scholar 

  17. Pluda JM, Yaarchoan R, Jaffe ES, Feuerstein IM, Solomon D, Steinberg SM, Wyvill KM, Raubitschek A, Katz D, Broder S: Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 113:276–282, 1990

    PubMed  Google Scholar 

  18. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, Slywotzky C, Pelicci P-G, Dalla-Favera R, Raphael B: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:744–753, 1988

    PubMed  Google Scholar 

  19. Lowenthal D, Strauss D, Campbell S, Gold J, Clarkson B, Koziner B: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 61:2325–2337, 1988

    PubMed  Google Scholar 

  20. Roithmann S,et al.: HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 2:289–295, 1991

    PubMed  Google Scholar 

  21. Shiramizu B, McGrath MS: Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 5(2):323–330, 1991

    PubMed  Google Scholar 

  22. Roithmann S, Andrieu J: Clinical and biological characteristics of malignant lymphomas in HIV-infected patients. Eur J Cancer 28A:1501–1508, 1991

    Google Scholar 

  23. Epstein LG, DiCarlo FJ, Joshi VV, Connor EM, Oleske JM, Kay D, Koenigsberger MR, Sharer LR: Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome. Pediatrics 82:355–363, 1988

    PubMed  Google Scholar 

  24. Miotti PG, Nelson KE, Dallabeetla GA, Farzadigon H, Margolick J, Clements ML: The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 262:779–783, 1989

    PubMed  Google Scholar 

  25. Bower M: The biology of HIV-associated lymphomas. Br J Cancer 1992

  26. Starzl T, Porter K, Iwatsuki S,et al.: Reversibility of lymphoma and lymphoproliferative lesions developing under cyclosporinesteroid therapy. Lancet 1:583–587, 1984

    PubMed  Google Scholar 

  27. Shibata D, Weiss L, Nathwani B, Brynes R, Levine A: Epstein Barr virus in benign lymph node biosies from individuals infects with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 77:1527–1533, 1991

    PubMed  Google Scholar 

  28. Neri A, Barriga F, Inghirami G,et al.: Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphomas. Blood 77:1092–95, 1992

    Google Scholar 

  29. Heriot K, Hallquist A, Tomar R: Paraproteinemia in patients with acquired immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome (LAS). Clin Chem 31:1224–1226, 1985

    PubMed  Google Scholar 

  30. Nath N, Wunderlick C, Darr F,et al.: Immunoglobulin level in blood reactive for antibodies to human immunodeficiency virus. J Clin Microbiol 25:364–369, 1987

    PubMed  Google Scholar 

  31. Lane H, Masur H, Edgar K, Whalen G, Rook A, Fauci A: Abnormalities of B-cell activation and immunodeficiency virus. J Clin Microbiol 25:364–369, 1987

    PubMed  Google Scholar 

  32. Yarchoan R, Redfield R, Broder S: Contribution of antibody producing B cells, or Epstein-Barr infected B Cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy associated virus. J Clin Invest 78:439–447, 1986

    PubMed  Google Scholar 

  33. Teeuwsen VJP, Logtenberg T, Siebelink KHJ, Lange JM, Goudsmit J, Uytdehaag FGCM, Osterhauss ADME: Analysis of the antigen-and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. J Immunol 139:2929–2935, 1987

    PubMed  Google Scholar 

  34. Pahwa S, Pahwa R, Saninger C, Gallo RC, Good RA: Influence of the human T-lymmphotropic virus lymphadenopathy-associated virus on functions of human lymphocytes: Evidence for immunosuppressive effects and poly clonal B-cell activation by banded viral prepartions. Proc Natl Acad Sci USA 82:8198–8202, 1985

    PubMed  Google Scholar 

  35. Kondo S, Shimizu A, Saito Y, Kinoshita M, Honjo T: Molecular basis for two different affinity states of the interleukin 2 receptor: Affinity conversion model. Proc Natl Acad Sci USA 83:9026–9029, 1986

    PubMed  Google Scholar 

  36. Schnittman S, Lane H, Higgins S, Folks T, Fauci A: Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 233:1084–1086, 1986

    PubMed  Google Scholar 

  37. Amadou A, Zamarchi R, Ciminale V, DelMistro A, Siervo S, Alberti A, Colombatti M, Chieco-Bianchi L: HIV-1-specific B cell activation. J Immunol 143:2146–2152, 1989

    PubMed  Google Scholar 

  38. Vega A, Guigo R, Smith TF: Autoimmune response in AIDS. Nature 345:26, 1990

    PubMed  Google Scholar 

  39. Berberian L, Goodglick L, Kipps T, Braun J: ImmunoglobulinVH3 gene products: Natural ligands for HIV gp120. Science 1588–1591, 1993

  40. Chirmule N, Kalyanaraman VS, Lederman S, Oyaizu N, Yagura H, Yellin MJ, Chess L, Pahwa S: HIV-gp 160-induced T celldependent B cell differentiation. J Immunol 150:2478–2486, 1993

    PubMed  Google Scholar 

  41. Boue F, Wallon C, Goujard C, Barre-Sinoussi F, Galanaud P, Delfraissy J-F: HIV induces IL-6 production by human B lymphocytes. J Immunol 148:3761–3767, 1992

    PubMed  Google Scholar 

  42. Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gissebrecht C, Michiels JF, Van Damme J, Taga T, Kishimoto T, Crevon MC, Galanaud P: Interleukin-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 80:498–504, 1992

    PubMed  Google Scholar 

  43. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289–1298, 1992

    PubMed  Google Scholar 

  44. Emilies D, Touton R, Raphael M, Peuchmaur M, Devergnee O, Rea D, Coumbraras J, Crevon M-C, Edelman L, Joab I, Galanaud P:In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22:2937–2942, 1992

    PubMed  Google Scholar 

  45. Konrad RJ, Kricka LJ, Goodman DBP, Goldman J, Silberstein LE: Myeloma-associated paraprotein directed against the HIV-1 p224 antigen in an HIV-1 seroopositive patient. N Engl J Med 328:1817–1819, 1993

    PubMed  Google Scholar 

  46. Ng VL HK, Reyes GR, Kaplan LD, Kharyam-Bashi H, McGrath MS: High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complex. Blood 71:1397–1401, 1988

    PubMed  Google Scholar 

  47. Ng VL CK, Hwang KM, Khayam-Bashi H, McGrath MS: The clinical significance of human immunodeficiency virus type-1 associated paraproteins. Blood 74:2471–2475, 1989

    PubMed  Google Scholar 

  48. Calabrese LH, Kelley DM, Myers A, O'Connell M, Easley K: Rheumatic symptoms and human immunodeficiency virus infection. Arthritis Rheum 34:257–263, 1991

    PubMed  Google Scholar 

  49. Morrow WJW, Isenberg DA, Sobol RE, Stricker RB, Kieber-Emmons T: AIDS virus infection and autoimmunity: A perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 40:515–5224, 1991

    Google Scholar 

  50. Schattner A, Rager-Zisman B: Virus-induced autoimmunity. Rev Infect Dis 12:204–222, 1990

    PubMed  Google Scholar 

  51. Valeriano-Marcet JL, Ravichandran L, Kerr LD: HIV associated sytstemic necrotizing vasculitis. J Rheumatol 17:1091–1093, 1990

    PubMed  Google Scholar 

  52. Vega MA, Guigdo R, Smith TF: Autoimmune response in AIDS. Nature (London) 345:26, 1990

    Google Scholar 

  53. Ziegler JL, Stites DP: Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol 41:305–313, 1986

    PubMed  Google Scholar 

  54. Adams LE, Donovan-Brand R, Friedman-Kien A, el Ramahi K, Hess EV: Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes. Clin Immunol Immunopathol 46:442–449, 1988

    PubMed  Google Scholar 

  55. Ardman B, Sikorski MA, Settles M, Staunton DE: Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal lymphocytes. J Exp Med 172:1151–1158, 1990

    PubMed  Google Scholar 

  56. Bloom EJ, Abrams DI, Rodgers G: Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 256:491–493, 1986

    PubMed  Google Scholar 

  57. Chams VT, Jouault T, Fenouillet E, Gluckman J-C, Klatzmann D: Detection of anti-CD autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. AIDS 2:353–361, 1988

    PubMed  Google Scholar 

  58. Gentric A, Blaschek M, Julien C, Jouquan J, Pennec Y, Berthelot J-M, Mottier R, Casburn-Budd R, Youinou R: Nonorgan-specific autoantibodies in individuals infected with type 1 human immunodeficiency virus. Clin Immunol Immunopathol 59:487–494, 1991

    PubMed  Google Scholar 

  59. Grant MD, Weaver MS, Tssoukas C, Hoffmann GW: Distribution of antibodies against denatured collagen in AIDS risk groups and homosexual AIDS patients suggests a link between autoimmunity and the immunopathogenesis of AIDS. J Immunol 144:1241–1250, 1990

    PubMed  Google Scholar 

  60. Kiprov D, Pfaeffl W, Parry G, Lippert R, Lang W, Miller: Antibody-mediated peripheral neuropathies associated with ARC and AIDS: successful treatment with plasmapherresis. J Clin Apheresis 4:3–7, 1988

    PubMed  Google Scholar 

  61. Klaassen RJL, Goldschmeding R, Dolman KM, Vlekke ABJ, Weigel HM, Eeftinck Schattenberk JKM, Mulder JW, Westedt ML, von dem Borne AEGK: Anti-neutrophil cytoplasmic autoantibodies in patients with syptomatic HIV infection. Clin Exp Immunol 87:24–30, 1992

    PubMed  Google Scholar 

  62. Kowalski M, Ardman B, Basiripour L, Lu Y, Blohm D, Haseltine W, Sodroski J: Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86:3346–3350, 1989

    PubMed  Google Scholar 

  63. Luizzi GM, Mastroinni CM, Vullo V, Jirillo E, Delia S, Riccio P: Cerebrospinal fluid myelin basic as predictive marker of demyelination in AIDS dementia complex. J Neuroimmunol 36:251–254, 1992

    PubMed  Google Scholar 

  64. Maclean C, Flegg PJ, Kilpatrick DC: Anticariolipin antibodies and HIV infection. Clin Exp Immunol 81:263–266, 1990

    PubMed  Google Scholar 

  65. Salim YS, Faber V, Wiik A, Andersen PL, Hoier-Madsen M, Mouritsen S: Anti-corticosteroid antibodies in AIDS patients. APMIS 96:889–894, 1988

    PubMed  Google Scholar 

  66. Thiriart C, Goudsmit J, Schellekens P, Barin F, Zagury D, DeWilde M, Bruck C: Antibodies to soluble CD4 in HIV-1 infected individuals. AIDS 2:345–351, 1988

    PubMed  Google Scholar 

  67. Weimer R, Daniel V, Zimmermann R, Schimpf K, Opelz G: Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients. Blood 77:133–140, 1991

    PubMed  Google Scholar 

  68. Pantaleo G, Graziosi C, Fauci A: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327–335, 1993

    PubMed  Google Scholar 

  69. Cleary M, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Sklar RL: Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97, 1986

    PubMed  Google Scholar 

  70. Friedman DF, Cho EA, Goldman J, Carmack CE, Besa EC, Hardy RR, Silberstein LE: The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med 174:525–537, 1991

    PubMed  Google Scholar 

  71. Cherepakhin V, Feigal E, Kipps TJ: Immunoglobulin heavy chain variable region genes expressed in AIDS-associated monoclonal B-cell lymphomas. Blood 80:116a, 1992

    Google Scholar 

  72. Andris JS, Johnson S, Zolla-Pazner S, Capra JD: Molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen driven response. Proc Natl Acad Sci USA 88:7783–7787, 1991

    PubMed  Google Scholar 

  73. Levine AN: Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8–20, 1992

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 19104, Philadelphia, Pennsylvania

    John G. Monroe & Leslie E. Silberstein

Authors
  1. John G. Monroe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie E. Silberstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Monroe, J.G., Silberstein, L.E. HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol 15, 61–68 (1995). https://doi.org/10.1007/BF01541733

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01541733

Key words

Search

Navigation